Condition: Non-small Cell Lung Cancer · Sponsor: BioNTech SE
This is a Phase 2/3, multisite, randomized, open-label study in participants with first-line non-small cell lung cancer (NSCLC). This study includes two substudies (substudy A and substudy B) that will recruit participants according to histological subtypes due to differences in chemotherapy choice for standard-of-care and type of NSCLC.
This description comes directly from the study's public registry record.
BioNTech clinical trials patient information · +49 6131 9084 · patients@biontech.de
Always discuss trial participation with your own doctor first.
| Birmingham Hematology and Oncology Associates LLC d/b/a Alabama Oncology | Birmingham, Alabama, United States | Recruiting |
| Alaska Oncology and Hematology, LLC | Anchorage, Alaska, United States | Recruiting |
| John Muir Clinical Research Center | Concord, California, United States | Recruiting |
| University Of California - San Diego Moores Cancer Center | La Jolla, California, United States | Recruiting |
| Clermont Oncology Center | Clermont, Florida, United States | Recruiting |
| Mid Florida Cancer Centers | Orange City, Florida, United States | Recruiting |
| Cleveland Clinic Florida - Martin North Hospital | Stuart, Florida, United States | Recruiting |
| H. Lee Moffit Cancer center and research institute | Tampa, Florida, United States | Recruiting |
| Cleveland Clinic Weston Hospital | Weston, Florida, United States | Recruiting |
| Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne, Indiana, United States | Recruiting |
| Physicians Clinic of Iowa | Cedar Rapids, Iowa, United States | Recruiting |
| Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics | Iowa City, Iowa, United States | Recruiting |
+ 249 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06712316